Is smoking beneficial for granulomatous lung diseases?

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 8, 2004, Pages 893-895

  Maier, Lisa A ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC PNEUMONITIS; ANTIBODY RESPONSE; CELLULAR IMMUNITY; EDITORIAL; HUMAN; IMMUNOMODULATION; LUNG BIOPSY; LUNG GRANULOMA; LUNG LAVAGE; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SARCOIDOSIS; SMOKING; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 1842607527     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2402023     Document Type: Editorial

References (16)

1. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-852.
2. Centers for Disease Control and Prevention. Cigarette smoking-attributable morbidity-United States, 2000. MMWR 2003;52:842-844.
3. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-377.
4. Blanchet M, Israël-Assayag E, Cormier Y. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med 2004;169:903-909.
5. Warren C. Extrinsic allergic alveolitis: A disease commoner in nonsmokers. Thorax 1977;32:567-573.
6. Ohtsuka Y, Munakata M, Tanimura K, Ukita H, Kusaka H, Masaki Y, Doi I, Ohe M, Amishima M, Homma Y, et al. Smoking promotes insidious and chronic farmer's lung disease, and deteriorates the clinical outcome. Intern Med 1995;34:966-971.
7. Douglas JG, Middleton WG, Gaddie J, Petrie GR, Choo-Kang YF, Prescott RJ, Crompton GK. Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986;41:787-791.
8. Newman L, Bresnitz EA, Rose C, Rossman M, Terrin ML, Barnard J, and the ACCESS Group. Environmental and occupational factors associated with sarcoidosis risk: A case control etiologic study of sarcoidosis. Am J Respir Crit Care Med 2001;163(5):A959.
9. Baldwin CI, Todd A, Bourke S, Allen A, Calvert JE. Pigeon fanciers' lung: effects of smoking on serum and salivary antibody responses to pigeon antigens. Clin Exp Immunol 1998;113:166-172.
10. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, Cox G, Stampfli MR. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004;30:202-211.
11. Valeyre D, Soler P, Clerici C, Pré J, Battesti J-P, Georges R, Hance AJ. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988;43:516-524.
12. Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 2003;109:365-373.
13. McCue JM, Link KL, Eaton SS, Freed BM. Exposure to cigarette tar inhibits ribonucleotide reductase and blocks lymphocyte proliferation. J Immunol 2000;165:6771-6775.
14. Matsunaga K, Klein TW, Friedman H, Yamamoto Y. Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001;167:6518-6524.
15. Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol 2000;106:280-287.
16. Strom KE, Eklund AG. Smoking does not prevent the onset of respiratory failure in sarcoidosis. Sarcoidosis 1993;10:26-28.